About Theraptosis
Theraptosis is a Healthcare company based in France founded in 2001. It develops innovative therapeutic molecules for oncology and neurodegenerative diseases. It operates on a B2B model. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. Its focus areas include Biotechnology and Therapeutics.
Company details
Theraptosis, established in 2001, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and oncology and neurodegenerative treatments. Develops innovative therapeutic molecules for oncology and neurodegenerative diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters France
- SectorsHealthcare
- Website theraptosis.com
- Legal Name Ironsource India Private Limited
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
Associated legal entities of Theraptosis
Theraptosis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Board of directors of Ironsource India Private Limited (Theraptosis)
Ironsource India Private Limited is the primary company behind Theraptosis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
Financials of Theraptosis
Figures of Ironsource India Private Limited, the primary company behind Theraptosis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for Theraptosis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theraptosis
Complete news archive for Theraptosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theraptosis
Theraptosis was founded in 2001.
Theraptosis is headquartered in France.
The primary company behind Theraptosis, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
Theraptosis, established in 2001, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and oncology and neurodegenerative treatments. Develops innovative therapeutic molecules for oncology and neurodegenerative diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Theraptosis operates through Ironsource India Private Limited.
The legal entities of Theraptosis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.